Supriya Lifescience Limited (NSE:SUPRIYA)
India
· Delayed Price · Currency is INR 580.85
-47.05 (-7.49%)
Mar 9, 2026, 3:30 PM IST
Supriya Lifescience Revenue
Supriya Lifescience had revenue of 2.06B INR in the quarter ending December 31, 2025, with 11.20% growth. This brings the company's revenue in the last twelve months to 7.35B, up 9.68% year-over-year. In the fiscal year ending March 31, 2025, Supriya Lifescience had annual revenue of 6.96B with 22.12% growth.
Revenue (ttm)
7.35B
Revenue Growth
+9.68%
P/S Ratio
6.36
Revenue / Employee
14.28M
Employees
515
Market Cap
46.75B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zota Health Care | 4.73B |
| Blue Jet Healthcare | 10.53B |
| Dishman Carbogen Amcis | 27.97B |
| Concord Biotech | 11.59B |
| Panacea Biotec | 6.06B |
| OneSource Specialty Pharma | 14.19B |
| Anthem Biosciences | 20.02B |
| TAKE Solutions | -70.53M |